This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
It covers significant safety alerts, recalls, new product approvals, and offers important tips on protecting patients.
Read the complete stories and watch or download the video program. You may have already received notification of some of these safety issues through the MedWatch E-list. However, many of these PSN stories contain video footage and demonstrations that may be especially useful to educators in healthcare facilities and academic institutions.
Stories in the October 2009 edition include:
New Colchicine Product and Dosing Regimen - FDA has approved Colcrys, the first single-ingredient oral colchicine product
Potentially Fatal Errors with Certain Glucose Test Strips -GDH-PQQ test strips cannot distinguish between glucose and other sugars contained in certain therapeutic products
Certain Lots of Teva Propofol Recalled - Vials in these lots may contain elevated endotoxin levels
Alaris (Medley) Infusion Systems Recalled -Affected devices may cause patients to be over or under-infused, leading to serious injury or death
Recall of Certain Hospira Devices - Defective cords may pose risk of fire, electric shock
“Nuby” Gel-filled Teethers Recalled - Gel inside teethers may be contaminated with bacteria
Safety Warning on Certain Body-building Products - Consumers should immediately stop taking any product that claims to contain steroids or steroid-like substances
